Capricor Therapeutics
CAPR
#7974
Rank
HK$2.26 B
Marketcap
HK$49.49
Share price
-4.36%
Change (1 day)
-57.79%
Change (1 year)

Capricor Therapeutics (CAPR) - Total debt

Total debt on the balance sheet as of September 2025 : HK$0.11 Billion

According to Capricor Therapeutics 's latest financial reports the company's total debt is HK$0.11 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Capricor Therapeutics - Total debt on balance sheet (from 2002 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$11.26 M-35.49%
2023-12-31HK$17.46 M-12.7%
2022-12-31HK$20 M-10.63%
2021-12-31HK$22.38 M807.45%
2020-12-31HK$2.46 M
2017-12-31N/A-100%
2016-12-31HK$0.10 B51.95%
2015-12-31HK$70.96 M-0.07%
2014-12-31HK$71.01 M131.17%
2013-12-31HK$30.72 M
2006-12-31HK$0.97 M80.23%
2005-12-31HK$0.53 M33.22%
2004-12-31HK$0.4 M41.04%
2003-12-31HK$0.28 M379.68%
2002-12-31HK$0.05 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Cytokinetics
CYTK
HK$9.31 B 8,129.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
HK$2.04 M-98.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$356.32 B 314,798.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$3.33 B 2,845.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$20.39 M-81.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
HK$4.29 M-96.20%๐Ÿ‡บ๐Ÿ‡ธ USA